Insmed (INSM) FY 2025 Conference September 05, 2025 08:00 AM ET Company ParticipantsTiago Fauth - Director - Equity Research Small/Mid Cap BiotechnologySara Bonstein - CFOTiago FauthAll right. Thanks, everyone, for joining us. I'm Tiago Fauci, biotech analyst here at Wells Fargo. We're joined today by Insmed Incorporated for a fireside chat. We have Sara here. Thanks so much for joining us.Sara BonsteinYeah, thanks for having us. Really appreciate it.Tiago FauthI'd like to just open up with some broad intro ...

Insmed (INSM) FY 2025 Conference September 05, 2025 08:00 AM ET Speaker0All right. Thanks, everyone, for joining us. I'm Tiago Fauci, biotech analyst here at Wells Fargo. We're joined today by Insmed Incorporated for a fireside chat. We have Sara here. Thanks so much for joining us.Speaker1Yeah, thanks for having us. Really appreciate it.Speaker0I'd like to just open up with some broad intro remarks. We have a lot of detailed questions that we usually get from investors that we want to walk through. Overall ...

June 10, 2025 Topline Results of Phase 2b Study of TPIP in PAH Patients TPIP: Treprostinil Palmitil Inhalation Powder | PAH: pulmonary arterial hypertension The forward-looking statements in this presentation are based upon the Company's current expectations and beliefs, and involve known and unknown risks, uncertainties and other factors, which may cause the Company's actual results, performance and achievements and the timing of certain events to differ materially from the results, performance, achievemen ...